We have found the following
-
A Hybrid Archetyping Approach for Late Lifecycle Planning
Market archetypes provide a structured way to simplify complexity without losing strategic nuance, however, for late lifecycle planning, not all pharma archetyping approaches are equally effective. -
Loss of Exclusivity: Key Factors Shaping Local Market Dynamics
Success post-loss of exclusivity is heavily determined by your local strategies and planning. We take a look at the key factors shaping local market dynamics and why they matter to your strategy. -
Going Beyond Indication Expansion: A Framework for Rethinking Lifecycle Management
Introducing a lifecycle management framework to help pharmaceutical teams go beyond indication expansion by considering the breadth, depth, and sustainability of an asset. -
Early Lifecycle Management: Your Compass for Unlocking Asset Value
Developing a new pharmaceutical asset is not unlike the voyage of cargo ship: success depends on having a compass to guide you. In pharma, that compass is early lifecycle management planning. -
Six Strategy Decision Points for Effective Lifecycle Management
Maximize pharma asset value with our infographic: Six Strategic Decision Points for balanced Lifecycle Management success. -
5 Best Practices In Late Lifecycle Management
Navigate brand challenges with tailored Lifecycle Management. Explore 5 key practices for success as your portfolio evolves. -
PM360 – When it Comes to Lifecycle Management, Integrate, Don’t Ignore Uncertainty
Discover PM360 Resource on Integration for Lifecycle Management Success. Neal Hansen from Align Strategy explains how effective risk integration enhances planning. -
How to Analyse Unmet Needs to Drive Opportunity
Capture and build on unmet needs during indication prioritisation. Avoid oversimplification to seize true opportunities for developmental assets. -
How to Define Your Addressable Patient Population
Amid disease population complexities, pharma must avoid overlooking valuable opportunities for innovative patient solutions. -
How to Plan Ahead for Multi-Indication Assets
Unlocking indication prioritisation complexities is possible. A strategic framework simplifies decision-making, fostering cross-functional collaboration and comprehensive considerations.
